Investigator(s):
The Lundquist Institute
SAN FRANCISCO – (June 18, 2013) – Men who lose sleep during the work week may be able to lower their risk of developing Type 2 diabetes by getting more hours of sleep, according to Los Angeles Biomedical Research Institute (LA BioMed) research findings presented today at The Endocrine Society’s 95th Annual Meeting in San Francisco.
Investigator(s):
The Lundquist Institute
Dr Matthew Budoff (Los Angeles Biomedical Research Institute, CA), a longtime researcher in the use of cardiac CT, described what he believes to be the most important uses for CT today [1].
First, CT angiography is emerging as “a single tool that gives us [information about] function and anatomy,” he told the audience.
Investigator(s):
Virender Rehan, MD
Turmeric, a key ingredient in spicy curry dishes, has long been known to have medicinal values. Now new research finds a substance in turmeric, curcumin, may provide lasting protection against potentially deadly lung damage in premature infants.
Investigator(s):
The Lundquist Institute
LOS ANGELES – (May 29, 2013) – Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center(LA BioMed) has named three new members to its board of directors.
The new members are Alex Popa, a vice president at The Capital Group in Los Angeles; H. Michael Smith, the national science and technology practice leader for HKS, Inc.; and Sussan Sharifian, president of Packair Airfreight, Inc and Packair Customs Brokers, Inc.
Investigator(s):
Carol D Berkowitz, MD, Mallory Witt, MD
LOS ANGELES – (May 28, 2013) – Carol Berkowitz, MD, and Mallory D. Witt, MD, lead researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), received the Serge & Yvette Dadone Clinical Teaching Award in Honor of Saleh Salehmoghaddam, M.D., a peer-reviewed recognition of their “outstanding dedication, innovation, and sustained excellence in clinical and classroom teaching,” according to the David Geffen School of Medicine at UCLA, which presented the awards.
Investigator(s):
Yan Xiong, MD, PhD
Drs. Arnold Bayer, Yan Qiong Xiong and Soo-Jin Yang, Faculty principal investigators in LA BioMed’s Division of Infectious Diseases, have recently been awarded three extramural grants for their collaborating programs in the study of Staphylococcus aureus infections, most specifically Methicillin-resistant Staphylococcus aureus (MRSA). Dr. Bayer’s $1.8 million grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID) represents continued funding for years 15-19 of this RO1-funded project, while Dr.
Investigator(s):
The Lundquist Institute
LOS ANGELES – (May 23, 2013) – Rubén D. Flores-Saaib, PhD, an experienced professional in the biomedical development field, recently joined the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) as the assistant vice president for business development, a newly created position to maximize the potential of intellectual property generated by the institute’s 100 investigators.
Investigator(s):
The Lundquist Institute
LOS ANGELES – (May 2, 2013) – Patients with increasing accumulations of coronary artery calcium were more than six times more likely to suffer from a heart attack or die from heart disease than patients who didn’t have increasing accumulations, according to a recent study published in the Journal of the American College of Cardiology.
Investigator(s):
The Lundquist Institute
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) honored two of its legendary physician-researchers Wednesday night and celebrated the 10th anniversary of the federal approval of a life-saving therapy developed at the institute.
Guests at the 10th Annual Legends event at Palos Verdes Golf Club celebrated the lives and legacies of David Heber, MD, PhD, and Ronald J. Nelson, MD, both of whom remembered fondly their early years at Harbor-UCLA Medical Center.
DTB_7692DTB_8417